SI
Sofinnova Investments’s Syndax Pharmaceuticals SNDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.3M | Sell |
1,524,440
-750,783
| -33% | -$7.03M | 0.87% | 30 |
|
2025
Q1 | $28M | Buy |
2,275,223
+1,616,596
| +245% | +$19.9M | 1.83% | 13 |
|
2024
Q4 | $8.71M | Sell |
658,627
-128,372
| -16% | -$1.7M | 0.63% | 35 |
|
2024
Q3 | $15.1M | Sell |
786,999
-1,366,670
| -63% | -$26.3M | 1.2% | 20 |
|
2024
Q2 | $44.2M | Buy |
2,153,669
+545,129
| +34% | +$11.2M | 2.3% | 11 |
|
2024
Q1 | $38.3M | Buy |
1,608,540
+532,754
| +50% | +$12.7M | 2.13% | 15 |
|
2023
Q4 | $23.2M | Buy |
1,075,786
+133,969
| +14% | +$2.9M | 1.3% | 21 |
|
2023
Q3 | $13.7M | Sell |
941,817
-640,474
| -40% | -$9.3M | 0.86% | 28 |
|
2023
Q2 | $33.1M | Buy |
1,582,291
+506,867
| +47% | +$10.6M | 2.17% | 14 |
|
2023
Q1 | $22.7M | Buy |
1,075,424
+372,350
| +53% | +$7.86M | 1.45% | 19 |
|
2022
Q4 | $17.9M | Buy |
703,074
+178,072
| +34% | +$4.53M | 1.06% | 22 |
|
2022
Q3 | $12.6M | Buy |
525,002
+111,574
| +27% | +$2.68M | 0.73% | 24 |
|
2022
Q2 | $7.95M | Sell |
413,428
-303,636
| -42% | -$5.84M | 0.66% | 29 |
|
2022
Q1 | $12.5M | Sell |
717,064
-234,162
| -25% | -$4.07M | 0.95% | 24 |
|
2021
Q4 | $20.8M | Buy |
951,226
+537,385
| +130% | +$11.8M | 1.22% | 21 |
|
2021
Q3 | $7.91M | Buy |
+413,841
| New | +$7.91M | 0.47% | 40 |
|
2021
Q2 | – | Sell |
-298,644
| Closed | -$6.68M | – | 72 |
|
2021
Q1 | $6.68M | Sell |
298,644
-74,265
| -20% | -$1.66M | 0.4% | 41 |
|
2020
Q4 | $8.29M | Buy |
+372,909
| New | +$8.29M | 0.49% | 38 |
|
2020
Q3 | – | Sell |
-91,964
| Closed | -$1.36M | – | 80 |
|
2020
Q2 | $1.36M | Buy |
+91,964
| New | +$1.36M | 0.09% | 57 |
|
2019
Q4 | – | Sell |
-243,150
| Closed | -$1.82M | – | 65 |
|
2019
Q3 | $1.82M | Buy |
243,150
+421
| +0.2% | +$3.15K | 0.16% | 56 |
|
2019
Q2 | $2.26M | Buy |
242,729
+29,370
| +14% | +$273K | 0.21% | 47 |
|
2019
Q1 | $1.12M | Sell |
213,359
-136,751
| -39% | -$718K | 0.11% | 54 |
|
2018
Q4 | $1.56M | Buy |
350,110
+176,998
| +102% | +$788K | 0.19% | 55 |
|
2018
Q3 | $1.4M | Buy |
173,112
+74,499
| +76% | +$602K | 0.12% | 54 |
|
2018
Q2 | $693K | Buy |
98,613
+86,489
| +713% | +$608K | 0.08% | 54 |
|
2018
Q1 | $173K | Buy |
+12,124
| New | +$173K | 0.03% | 47 |
|